Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,092 | -3,969 | -2,279 | -8,242 | -6,794 |
| Depreciation Amortization | 35 | 19 | 6 | 164 | 157 |
| Accounts receivable | 134 | 116 | 1 | -179 | -3 |
| Accounts payable and accrued liabilities | 290 | -132 | -62 | -607 | -242 |
| Other Working Capital | 1,047 | 561 | 550 | 141 | 547 |
| Other Operating Activity | 88 | 334 | 179 | 2,624 | 1,994 |
| Operating Cash Flow | $-4,499 | $-3,071 | $-1,604 | $-6,098 | $-4,340 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -25 | -18 | -28 | -28 |
| Investing Cash Flow | $-25 | $-25 | $-18 | $-28 | $-28 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 0 | 4,935 | 4,741 |
| Debt Repayment | -225 | -155 | -70 | -276 | -217 |
| Common Stock Issued | 6,003 | 6,003 | 0 | 26 | 26 |
| Other Financing Activity | -574 | -460 | 0 | 5,059 | 0 |
| Financing Cash Flow | $5,204 | $5,388 | $-70 | $9,744 | $4,550 |
| Beginning Cash Position | 3,697 | 3,697 | 3,697 | 79 | 79 |
| End Cash Position | 4,377 | 5,989 | 2,005 | 3,697 | 261 |
| Net Cash Flow | $680 | $2,292 | $-1,692 | $3,618 | $182 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,499 | -3,071 | -1,604 | -6,098 | -4,340 |
| Capital Expenditure | -25 | -25 | -18 | -28 | -28 |
| Free Cash Flow | -4,524 | -3,096 | -1,622 | -6,126 | -4,368 |